CN105338981B - 固体药用组合物 - Google Patents

固体药用组合物 Download PDF

Info

Publication number
CN105338981B
CN105338981B CN201480036230.1A CN201480036230A CN105338981B CN 105338981 B CN105338981 B CN 105338981B CN 201480036230 A CN201480036230 A CN 201480036230A CN 105338981 B CN105338981 B CN 105338981B
Authority
CN
China
Prior art keywords
pharmaceutical composition
sodium
solid pharmaceutical
acid
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480036230.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN105338981A (zh
Inventor
内田浩
花田真隆
宫崎义
宫崎义一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of CN105338981A publication Critical patent/CN105338981A/zh
Application granted granted Critical
Publication of CN105338981B publication Critical patent/CN105338981B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201480036230.1A 2013-04-25 2014-04-24 固体药用组合物 Active CN105338981B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013-092169 2013-04-25
JP2013092169 2013-04-25
PCT/JP2014/002309 WO2014174847A1 (ja) 2013-04-25 2014-04-24 固形医薬組成物

Publications (2)

Publication Number Publication Date
CN105338981A CN105338981A (zh) 2016-02-17
CN105338981B true CN105338981B (zh) 2017-10-13

Family

ID=51791435

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480036230.1A Active CN105338981B (zh) 2013-04-25 2014-04-24 固体药用组合物

Country Status (6)

Country Link
US (1) US9687453B2 (https=)
EP (1) EP2990039A4 (https=)
JP (3) JP5700740B1 (https=)
CN (1) CN105338981B (https=)
CA (1) CA2910121A1 (https=)
WO (1) WO2014174847A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9603804B2 (en) 2013-04-25 2017-03-28 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition
US10154993B2 (en) * 2014-10-23 2018-12-18 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition
EP3305294A4 (en) * 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. AQUEOUS MEDICINE
JP6031217B1 (ja) * 2015-06-02 2016-11-24 杏林製薬株式会社 水性液剤
JP6675396B2 (ja) * 2015-06-02 2020-04-01 杏林製薬株式会社 水性液剤
WO2016195021A1 (ja) * 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
JP6031216B1 (ja) * 2015-06-02 2016-11-24 杏林製薬株式会社 水性液剤
KR20200013714A (ko) * 2017-05-31 2020-02-07 베링거 인겔하임 인터내셔날 게엠베하 (e)-4-(2-(아미노메틸)-3-플루오로알릴옥시)-n-3급-부틸벤즈아미드를 포함하는 약제학적 조성물 및 약제학적 투여 형태, 이들의 제조 방법, 이의 치료 방법 및 용도
US12083227B2 (en) 2017-08-18 2024-09-10 Abbvie Inc. Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
MX2020001877A (es) 2017-08-18 2020-09-14 Abbvie Inc Formulaciones farmacéuticas para tratar la endometriosis, los fibromas uterinos, el síndrome de ovario poliquístico o la adenomiosis.
CN116410080B (zh) * 2021-12-31 2025-09-23 万华化学集团股份有限公司 一种异甲基紫罗兰酮生产废盐水中醋酸钾的回收方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1505515A (zh) * 2001-02-27 2004-06-16 ʵ 头孢泊肟酯的口服药物组合物
CN1849316A (zh) * 2003-09-10 2006-10-18 杏林制药株式会社 7－(4－取代－3－环丙基氨基甲基－1－吡咯烷基)喹诺酮羧酸衍生物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524001D0 (en) 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
ATE232728T1 (de) 1998-03-03 2003-03-15 Dae Woong Pharma Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen
AT413647B (de) 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
DE10048510A1 (de) 2000-09-29 2002-05-16 Fresenius Kabi De Gmbh Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
ES2297067T3 (es) 2003-03-19 2008-05-01 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Composiciones farmaceuticas no higroscopicas que contienen acidos quinolinacarboxilicos de hidratados.
MX2007000336A (es) 2004-07-02 2007-03-28 Daiichi Seiyaku Co Composicion medicinal que contiene quinolona.
AU2005283422C1 (en) 2004-09-17 2017-02-02 Eisai R & D Management Co., Ltd. Medicinal composition
WO2006059716A1 (ja) 2004-12-03 2006-06-08 Takeda Pharmaceutical Company Limited 固形製剤
JP2006298811A (ja) 2005-04-20 2006-11-02 Taiyo Yakuhin Kogyo Kk ゲル化抑制製剤の設計
SA112330992B1 (ar) * 2011-11-10 2015-09-13 كيورين فارماسوتيكال كو.، ليمتد صورة متبلرة من 7-{(s4، s3)-3-[(سيكلو بروبيل أمينو) ميثيل]-4-فلورو بيروليدين-1-يل}-6-فلورو-1-(2-فلورو إيثيل)- 8-ميثوكسي-4-أوكسو-1، 4-داي هيدرو كينولين-3- حمض كربوكسيلي
JP6050322B2 (ja) 2012-03-29 2016-12-21 杏林製薬株式会社 カプセル製剤
WO2013145750A1 (ja) 2012-03-29 2013-10-03 杏林製薬株式会社 カプセル製剤
US9603804B2 (en) 2013-04-25 2017-03-28 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1505515A (zh) * 2001-02-27 2004-06-16 ʵ 头孢泊肟酯的口服药物组合物
CN1849316A (zh) * 2003-09-10 2006-10-18 杏林制药株式会社 7－(4－取代－3－环丙基氨基甲基－1－吡咯烷基)喹诺酮羧酸衍生物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Quinolones: structure-activity relationships and future predictions;G. S. TILLOTSON;《J. Med. Microbiol.》;19961231;第44卷;第320-324页 *
Stability Indicating Methods for the Determination of Some Fluoroquinolones in the Presence of Their Decarboxylated Degradates;Maissa Yacoub SALEM等;《Chem. Pharm. Bull.》;20061231;第54卷(第12期);第1625-1632页 *

Also Published As

Publication number Publication date
EP2990039A4 (en) 2017-02-22
CN105338981A (zh) 2016-02-17
WO2014174847A1 (ja) 2014-10-30
JP2015110646A (ja) 2015-06-18
JP5700740B1 (ja) 2015-04-15
EP2990039A1 (en) 2016-03-02
US20160074330A1 (en) 2016-03-17
JP2018199713A (ja) 2018-12-20
US9687453B2 (en) 2017-06-27
JP6397778B2 (ja) 2018-09-26
JP6689333B2 (ja) 2020-04-28
JPWO2014174847A1 (ja) 2017-02-23
CA2910121A1 (en) 2014-10-30

Similar Documents

Publication Publication Date Title
CN105338981B (zh) 固体药用组合物
CN105338982B (zh) 固体药用组合物
JP6876758B2 (ja) ブルトンチロシンキナーゼの阻害剤を含む剤形組成物
EP3616696B1 (en) Orally administrable enzalutamide-containing pharmaceutical composition
US10583087B2 (en) Pharmaceutical composition for oral administration
WO2020070147A1 (en) Pharmaceutical composition comprising lenvatinib esylate or tosylate
CN103687596B (zh) 固态医药组合物
WO2009123169A1 (ja) アミド誘導体含有医薬組成物
CA3108993C (en) Pharmaceutical composition for oral administration
JP6018334B2 (ja) 固形医薬組成物
JPWO2015199115A1 (ja) 経口投与用医薬組成物
HK40025159B (en) Orally administrable enzalutamide-containing pharmaceutical composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: Japan Tokyo Chiyoda Kanda Surugadai four chome 6 GA

Patentee after: KYORIN PHARMACEUTICAL Co.,Ltd.

Address before: Japan Tokyo Chiyoda Kanda Surugadai four chome 6 GA

Patentee before: Xinglin Holding Co.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20231226

Address after: Japan Tokyo Chiyoda Kanda Surugadai four chome 6 GA

Patentee after: Xinglin Holding Co.

Address before: Japan Tokyo Chiyoda Kanda Surugadai four chome 6 GA

Patentee before: KYORIN PHARMACEUTICAL Co.,Ltd.

CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: 3-7 Otemachi 1-chome, Chiyoda ku, Tokyo, Japan

Patentee after: KYORIN PHARMACEUTICAL Co.,Ltd.

Country or region after: Japan

Address before: Japan Tokyo Chiyoda Kanda Surugadai four chome 6 GA

Patentee before: KYORIN PHARMACEUTICAL Co.,Ltd.

Country or region before: Japan